Christopher Gibson
Principal investigator, leads Recursion Pharmaceuticals, LLC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.2MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $4.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 22, 2020 | NIH | SBIR Phase II Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction | $448K | Recursion Pharmaceuticals, LLC |
| Jun 7, 2019 | NIH | SBIR Phase II Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction | $434K | Recursion Pharmaceuticals, LLC |
| Sep 24, 2018 | NIH | SBIR Phase II Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction | $509K | Recursion Pharmaceuticals, LLC |
| Sep 9, 2016 | NIH | SBIR Phase II Novel Methodology for Identification of Senolytics that Reduce Age-related Disease and Dysfunction | $223K | Recursion Pharmaceuticals, LLC |
| Feb 22, 2016 | NIH | SBIR Phase II Expansion of an efficient drug repurposing platform for rare genetic diseases. | $650K | Recursion Pharmaceuticals, LLC |
| Sep 18, 2015 | NIH | SBIR Phase I Application of an efficient drug repurposing platform to identify treatments for Cornelia De Lange Syndrome | $225K | Recursion Pharmaceuticals, LLC |
| Aug 15, 2015 | NIH | SBIR Phase I HLS13-04 High-Content High-Throughput Screen for Diamond Blackfan Anemia Treatments | $217K | Recursion Pharmaceuticals, LLC |
| Mar 1, 2015 | NIH | SBIR Phase II Expansion of an efficient drug repurposing platform for rare genetic diseases. | $1.5M | Recursion Pharmaceuticals, LLC |
Peer ranks
Federal funding#368
Awards as PI#190
Patents#273
Companies
- Recursion Pharmaceuticals, LLCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.